{"id":"https://openalex.org/W2072033476","doi":"https://doi.org/10.1097/icu.0b013e3283386783","title":"Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review","display_name":"Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review","alternate_titles":[],"publication_year":2010,"publication_date":"2010-04-14","ids":{"openalex":"https://openalex.org/W2072033476","doi":"https://doi.org/10.1097/icu.0b013e3283386783","mag":"2072033476","pmid":"https://pubmed.ncbi.nlm.nih.gov/20393293"},"language":"en","primary_location":{"id":"doi:10.1097/icu.0b013e3283386783","doi":"https://doi.org/10.1097/icu.0b013e3283386783","is_oa":false,"landing_page_url":"https://doi.org/10.1097/icu.0b013e3283386783","pdf_url":null,"source":{"id":"https://openalex.org/S145244763","display_name":"Current Opinion in Ophthalmology","issn_l":"1040-8738","issn":["1040-8738","1080-8132","1531-7021"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Ophthalmology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2072033476"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010569274","display_name":"Christine M. Schmucker","orcid":"https://orcid.org/0000-0002-1188-3158","observed_orcids":["https://orcid.org/0000-0002-1188-3158"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Christine Schmucker","raw_affiliation_strings":["German Cochrane Centre, University Medical Centre Freiburg, Germany. schmucker@cochrane.de","German Cochrane Centre, University Medical Centre Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Cochrane Centre, University Medical Centre Freiburg, Germany. schmucker@cochrane.de","institution_ids":["https://openalex.org/I2801240073"]},{"raw_affiliation_string":"German Cochrane Centre, University Medical Centre Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015645964","display_name":"Christoph Ehlken","orcid":"https://orcid.org/0000-0001-7388-7173","observed_orcids":["https://orcid.org/0000-0001-7388-7173"]},"institutions":[{"id":"https://openalex.org/I161046081","display_name":"University of Freiburg","ror":"https://ror.org/0245cg223","country_code":"DE","type":"education","lineage":["https://openalex.org/I161046081"]},{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph Ehlken","raw_affiliation_strings":["University Eye Hospital, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Eye Hospital, Freiburg, Germany","institution_ids":["https://openalex.org/I161046081","https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109892220","display_name":"Lutz Lothar Hansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161046081","display_name":"University of Freiburg","ror":"https://ror.org/0245cg223","country_code":"DE","type":"education","lineage":["https://openalex.org/I161046081"]},{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Lutz L Hansen","raw_affiliation_strings":["University Eye Hospital, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Eye Hospital, Freiburg, Germany","institution_ids":["https://openalex.org/I161046081","https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109992192","display_name":"Gerd Antes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gerd Antes","raw_affiliation_strings":["German Cochrane Centre, University Medical Centre Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Cochrane Centre, University Medical Centre Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110467726","display_name":"Hansjuergen Agostini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161046081","display_name":"University of Freiburg","ror":"https://ror.org/0245cg223","country_code":"DE","type":"education","lineage":["https://openalex.org/I161046081"]},{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hansjuergen T Agostini","raw_affiliation_strings":["University Eye Hospital, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Eye Hospital, Freiburg, Germany","institution_ids":["https://openalex.org/I161046081","https://openalex.org/I2801240073"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105885091","display_name":"Monika Lelgemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180437899","display_name":"University of Bremen","ror":"https://ror.org/04ers2y35","country_code":"DE","type":"education","lineage":["https://openalex.org/I180437899"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Monika Lelgemann","raw_affiliation_strings":["Health Technology Assessment Centre, University Bremen, Bremen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Technology Assessment Centre, University Bremen, Bremen, Germany","institution_ids":["https://openalex.org/I180437899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5010569274"],"corresponding_institution_ids":["https://openalex.org/I2801240073"],"apc_list":null,"apc_paid":null,"fwci":1.3942,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.77522124,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"21","issue":"3","first_page":"218","last_page":"226"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8740000128746033},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/age-related-macular-degeneration","display_name":"age-related macular degeneration","score":0.9789999723434448},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.9570000171661377},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9629999995231628},{"id":"https://openalex.org/keywords/photodynamic-therapy","display_name":"photodynamic therapy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.878000020980835},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.7369999885559082},{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.871999979019165},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.5860000252723694},{"id":"https://openalex.org/keywords/treatment-interval","display_name":"treatment interval","score":0.421999990940094}],"concepts":[{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.957042932510376},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9541932344436646},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9472807049751282},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.7798386812210083},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6101291179656982},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.603271484375},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5987496376037598},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.5580962896347046},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44061240553855896},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.21282482147216797},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20809954404830933},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12336325645446777}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007267","descriptor_name":"Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014822","descriptor_name":"Vitreous Body","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/icu.0b013e3283386783","doi":"https://doi.org/10.1097/icu.0b013e3283386783","is_oa":false,"landing_page_url":"https://doi.org/10.1097/icu.0b013e3283386783","pdf_url":null,"source":{"id":"https://openalex.org/S145244763","display_name":"Current Opinion in Ophthalmology","issn_l":"1040-8738","issn":["1040-8738","1080-8132","1531-7021"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Ophthalmology","raw_type":"journal-article"},{"id":"pmid:20393293","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20393293","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in ophthalmology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W1513613431","https://openalex.org/W1542061551","https://openalex.org/W1910188440","https://openalex.org/W1969775043","https://openalex.org/W1975926216","https://openalex.org/W1975965108","https://openalex.org/W1984850323","https://openalex.org/W1993244458","https://openalex.org/W1995450730","https://openalex.org/W1996044788","https://openalex.org/W1998074953","https://openalex.org/W1999611557","https://openalex.org/W2002842760","https://openalex.org/W2005340221","https://openalex.org/W2014559473","https://openalex.org/W2015525520","https://openalex.org/W2015805580","https://openalex.org/W2020050260","https://openalex.org/W2021496037","https://openalex.org/W2023523208","https://openalex.org/W2024416781","https://openalex.org/W2025980212","https://openalex.org/W2029119558","https://openalex.org/W2037780881","https://openalex.org/W2038711498","https://openalex.org/W2040326718","https://openalex.org/W2044157838","https://openalex.org/W2055385676","https://openalex.org/W2065425407","https://openalex.org/W2068742492","https://openalex.org/W2071778174","https://openalex.org/W2073559780","https://openalex.org/W2075634939","https://openalex.org/W2080886828","https://openalex.org/W2085712747","https://openalex.org/W2085945127","https://openalex.org/W2090387132","https://openalex.org/W2090779239","https://openalex.org/W2109539100","https://openalex.org/W2123232376","https://openalex.org/W2124415048","https://openalex.org/W2128076015","https://openalex.org/W2134954483","https://openalex.org/W2158029475","https://openalex.org/W2159452891","https://openalex.org/W2159490014","https://openalex.org/W2165066800","https://openalex.org/W2166241707","https://openalex.org/W2168787182","https://openalex.org/W2169580554","https://openalex.org/W2202171356","https://openalex.org/W2233259956","https://openalex.org/W2397634329","https://openalex.org/W2915852396","https://openalex.org/W4285719527","https://openalex.org/W6680034198"],"related_works":["https://openalex.org/W7100855956","https://openalex.org/W2067731615","https://openalex.org/W3022795090","https://openalex.org/W2081680826","https://openalex.org/W2212725224","https://openalex.org/W1737347230","https://openalex.org/W4292631600","https://openalex.org/W2159562236","https://openalex.org/W196084748","https://openalex.org/W1990631195"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"We":[3],"conducted":[4,207],"a":[5,36,166],"systematic":[6],"review":[7],"to":[8,22,60],"evaluate":[9],"whether":[10],"the":[11,15,49,99,118,145,150,163,170,183,191],"existing":[12],"evidence":[13],"justifies":[14],"intravitreal":[16,212],"use":[17,153],"of":[18,44,51,120,132,147,154,172,186],"bevacizumab":[19,34,113,155],"in":[20,24,39,48,89,139,159,169],"comparison":[21,50],"ranibizumab":[23,52,115],"age-related":[25],"macular":[26],"degeneration.":[27],"RECENT":[28],"FINDINGS:":[29],"Compared":[30],"with":[31,53,78],"photodynamic":[32,54],"therapy,":[33],"shows":[35],"relative":[37],"improvement":[38,57],"visual":[40,90],"acuity":[41,91],"that":[42,103],"is":[43,65,82,123,156,182],"similar":[45],"size":[46],"as":[47],"therapy":[55],"(relative":[56],"from":[58],"30":[59],"35%).":[61],"However,":[62],"this":[63,121],"finding":[64,122],"based":[66],"on":[67],"one":[68],"randomized":[69,208],"controlled":[70,148,209],"trial":[71],"including":[72],"less":[73,110],"than":[74,114],"50":[75],"patients":[76,173],"treated":[77],"bevacizumab.":[79,142,213],"Also,":[80],"nothing":[81],"known":[83],"about":[84],"long-term":[85],"(>12":[86],"months)":[87],"improvements":[88],"and":[92,105,135],"optimal":[93],"treatment":[94],"intervals":[95],"for":[96,193],"bevacizumab.Regarding":[97],"safety,":[98],"published":[100],"literature":[101],"indicates":[102],"ocular":[104],"systemic":[106],"adverse":[107,133],"effects":[108,134],"are":[109],"frequent":[111],"under":[112],"treatment.":[116],"But":[117],"validity":[119],"strongly":[124],"limited":[125],"by":[126],"inadequate":[127],"reporting,":[128],"an":[129],"unsystematic":[130],"evaluation":[131],"short":[136],"follow-up":[137],"times":[138],"studies":[140,195],"evaluating":[141,211],"SUMMARY:":[143],"Given":[144],"lack":[146],"data,":[149],"widespread":[151],"off-label":[152],"not":[157],"justified":[158],"clinical":[160],"practice.":[161],"On":[162],"other":[164],"hand,":[165],"major":[167],"challenge":[168],"management":[171],"who":[174],"require":[175],"repeated":[176],"antivascular":[177],"endothelial":[178,199],"growth":[179,200],"factor":[180,201],"injections":[181],"high":[184],"cost":[185],"ranibizumab.":[187],"This":[188],"dilemma":[189],"underlines":[190],"need":[192],"head-to-head":[194],"comparing":[196],"both":[197],"vascular":[198],"antibodies,":[202],"or,":[203],"at":[204],"least,":[205],"well":[206],"trials":[210]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2072033476","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
